Univest
Univest
  • Markets
  • 3 Oleochemical Additives Maker, Contract Drug Development and Manufacturing Company and Generic Drug Maker Stocks With a Strong Future Roadmap: Fine Organic Industries, Anthem Biosciences and Alembic Pharmaceuticals

    • October 30, 2026
    • Posted by: Kunal Singla
    • Category: Best Stocks
    No Comments
    3 Oleochemical Additives Maker, Contract Drug Development and Manufacturing Company and Generic Drug Maker Stocks With a Strong Future Roadmap: Fine Organic Industries, Anthem Biosciences and Alembic Pharmaceuticals

    Oleochemical, Contract Pharma and Generic Stocks with a strong future roadmap: Fine Organic Industries, Anthem Biosciences and Alembic Pharmaceuticals. Compare price, valuation, return on equity and revenue growth as of 28 October 2026.

    read more
  • 3 US Generics Exporter, Anti-Infectives Franchise Owner and Biggest Indian Drug Maker by Value Stocks With a Strong Future Roadmap: Alembic Pharmaceuticals, Alkem Laboratories and Sun Pharma

    • October 29, 2026
    • Posted by: Neeraj Pandey
    • Category: Best Stocks
    No Comments
    3 US Generics Exporter, Anti-Infectives Franchise Owner and Biggest Indian Drug Maker by Value Stocks With a Strong Future Roadmap: Alembic Pharmaceuticals, Alkem Laboratories and Sun Pharma

    Generics, Anti-infective and Pharma Leader with a strong future roadmap: Alembic Pharmaceuticals, Alkem Laboratories and Sun Pharma. Compare price, valuation, return on equity and revenue growth as of 27 October 2026.

    read more
  • 3 Specialty Generics Maker, Respiratory Medicines and Global Generics Leader and Injectables and Hospital Products Company Stocks With a Strong Future Roadmap: Alembic Pharmaceuticals, Cipla and Emcure Pharmaceuticals

    • October 28, 2026
    • Posted by: Neeraj Pandey
    • Category: Best Stocks
    No Comments
    3 Specialty Generics Maker, Respiratory Medicines and Global Generics Leader and Injectables and Hospital Products Company Stocks With a Strong Future Roadmap: Alembic Pharmaceuticals, Cipla and Emcure Pharmaceuticals

    Respiratory and Hospital Medicine Pharma Stocks with a strong future roadmap: Alembic Pharmaceuticals, Cipla and Emcure Pharmaceuticals. Compare price, valuation, return on equity and revenue growth as of 27 October 2026.

    read more
  • 3 Specialty Generics and Branded Formulations Maker, Domestic Brands Specialist and Oncology Focused Drug Maker Stocks With a Strong Future Roadmap: Alembic Pharmaceuticals, JB Chemicals and Pharmaceuticals and Natco Pharma

    • October 28, 2026
    • Posted by: Ankit Jaiswal
    • Category: Best Stocks
    No Comments
    3 Specialty Generics and Branded Formulations Maker, Domestic Brands Specialist and Oncology Focused Drug Maker Stocks With a Strong Future Roadmap: Alembic Pharmaceuticals, JB Chemicals and Pharmaceuticals and Natco Pharma

    Specialty and Complex Generics Pharma Stocks with a strong future roadmap: Alembic Pharmaceuticals, JB Chemicals and Pharmaceuticals and Natco Pharma. Compare price, valuation, return on equity and revenue growth as of 27 October 2026.

    read more
  • 3 Generic Formulations Maker, Latin America Branded Generics Seller and Leading Chronic Therapy Pharma Company Stocks With a Strong Future Roadmap: Alembic Pharmaceuticals, Caplin Point Laboratories and Torrent Pharmaceuticals

    • October 28, 2026
    • Posted by: Lakshit Sharma
    • Category: Best Stocks
    No Comments
    3 Generic Formulations Maker, Latin America Branded Generics Seller and Leading Chronic Therapy Pharma Company Stocks With a Strong Future Roadmap: Alembic Pharmaceuticals, Caplin Point Laboratories and Torrent Pharmaceuticals

    Chronic Therapy and Generic Formulation Stocks with a strong future roadmap: Alembic Pharmaceuticals, Caplin Point Laboratories and Torrent Pharmaceuticals. Compare price, valuation, return on equity and revenue growth as of 27 October 2026.

    read more
  • 3 US Generics and Branded Medicines Company, Global Generics Maker and Chronic Therapy Brands Company Stocks With a Strong Future Roadmap: Alembic Pharmaceuticals, Dr. Reddy’s Laboratories and Eris Lifesciences

    • October 27, 2026
    • Posted by: Lakshit Sharma
    • Category: Best Stocks
    No Comments
    3 US Generics and Branded Medicines Company, Global Generics Maker and Chronic Therapy Brands Company Stocks With a Strong Future Roadmap: Alembic Pharmaceuticals, Dr. Reddy's Laboratories and Eris Lifesciences

    US Generics and Chronic Brand Pharma Stocks with a strong future roadmap: Alembic Pharmaceuticals, Dr. Reddy’s Laboratories and Eris Lifesciences. Compare price, valuation, return on equity and revenue growth as of 26 October 2026.

    read more
  • 3 US Generics and Branded Medicines Company, Pain and Anti-Malarial Brands Leader and Soft Gel Capsules Producer Stocks With a Strong Future Roadmap: Alembic Pharmaceuticals, Ipca Laboratories and Strides Pharma Science

    • October 27, 2026
    • Posted by: Harsh Piplani
    • Category: Best Stocks
    No Comments
    3 US Generics and Branded Medicines Company, Pain and Anti-Malarial Brands Leader and Soft Gel Capsules Producer Stocks With a Strong Future Roadmap: Alembic Pharmaceuticals, Ipca Laboratories and Strides Pharma Science

    US Generics, Pain Care Brand and Soft Gel Stocks with a strong future roadmap: Alembic Pharmaceuticals, Ipca Laboratories and Strides Pharma Science. Compare price, valuation, return on equity and revenue growth as of 26 October 2026.

    read more
  • 3 Fermentation Ingredients Maker, Generics and Branded Medicines Company and Portable Molecular Testing Firm Stocks With a Strong Future Roadmap: Concord Biotech, Alembic Pharmaceuticals and Molbio Diagnostics

    • October 27, 2026
    • Posted by: Kunal Singla
    • Category: Best Stocks
    No Comments
    3 Fermentation Ingredients Maker, Generics and Branded Medicines Company and Portable Molecular Testing Firm Stocks With a Strong Future Roadmap: Concord Biotech, Alembic Pharmaceuticals and Molbio Diagnostics

    Fermentation API, Generics and Testing Stocks with a strong future roadmap: Concord Biotech, Alembic Pharmaceuticals and Molbio Diagnostics. Compare price, valuation, return on equity and revenue growth as of 26 October 2026.

    read more
  • 3 Anti-Retroviral and Ingredients Leader, Excipients and Food Additive Maker and US Generics Exporter Stocks With a Strong Future Roadmap: Laurus Labs, Sudeep Pharma and Alembic Pharmaceuticals

    • October 26, 2026
    • Posted by: Neeraj Pandey
    • Category: Best Stocks
    No Comments
    3 Anti-Retroviral and Ingredients Leader, Excipients and Food Additive Maker and US Generics Exporter Stocks With a Strong Future Roadmap: Laurus Labs, Sudeep Pharma and Alembic Pharmaceuticals

    API, Excipient and Generic Pharma Stocks with a strong future roadmap: Laurus Labs, Sudeep Pharma and Alembic Pharmaceuticals. Compare price, valuation, return on equity and revenue growth as of 23 October 2026.

    read more
  • 3 Research-Driven Drug Maker, Complex Generics Supplier and Over-the-Counter Medicine Exporter Stocks With a Strong Future Roadmap: Glenmark Pharmaceuticals, Alembic Pharmaceuticals and Marksans Pharma

    • October 26, 2026
    • Posted by: Chaitanya Auti
    • Category: Best Stocks
    No Comments
    3 Research-Driven Drug Maker, Complex Generics Supplier and Over-the-Counter Medicine Exporter Stocks With a Strong Future Roadmap: Glenmark Pharmaceuticals, Alembic Pharmaceuticals and Marksans Pharma

    Branded Generics and Export Pharma Stocks with a strong future roadmap: Glenmark Pharmaceuticals, Alembic Pharmaceuticals and Marksans Pharma. Compare price, valuation, return on equity and revenue growth as of 23 October 2026.

    read more
  • 1
  • 2
  • 3